Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: Dosage requirements and pharmacokinetic studies
Gene D. Morse, Richard C. Reichman, Margaret A. Fischl, Michael Para, John Leedom, William Powderly, Lisa M. Demeter, Lionel Resnick, Yiannis Bassiakos, Joseph Timpone, Steve Cox, Donald Batts
Dive into the research topics of 'Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: Dosage requirements and pharmacokinetic studies'. Together they form a unique fingerprint.